dupilumab
sanofi,regeneron
['dupixent', 'dupilumab']
dupixent (dupilumab) late-breaking phase 3 data at the eadv 2022 congress showed ... do not change or stop your corticosteroid medicine or other asthma medicine without talking to your healthcare provider. this may cause other symptoms ...
#TheAsthmaCures https://t.co/vRkYeArZWg helping those with chronic #asthma https://t.co/7SMiyxzFdG resolving https://t.co/nIlzNga34W https://t.co/T67YXQ3eBZ